Jing Hu

Jing combines 8 years of hands-on biochemistry research with over a decade leading global software teams at major biopharma companies. She spearheaded AI system proofs-of-concept that accelerated protein structure analysis from months to days, a 100x leap inspired by breakthroughs like AlphaFold.

Now devoted full-time to AI research, journalism, and public speaking, Jing regularly interviews leading researchers on AI’s transformative impact on enterprise adoption and workflows. In 2025, she chaired the AI stage at the UK’s TechShow London, engaging with industry leaders from AXA, Bupa, Pandora, Mastercard, and more.

Jing champions AI that enhances human expertise rather than replaces it—a vision shaped by her rare combination of deep scientific insight and technology leadership.